Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

WBI-1001

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Efficacy and safety of topical WBI‐1001 in patients with mild to severe atopic dermatitis: results from a 12‐week, multicentre, randomized, placebo‐controlled double‐blind trial
Background  There is a need for the development of novel nonsteroidal topical drugs for the treatment of atopic dermatitis (AD). 
2012
2012
Efficacy and safety of topical WBI‐1001 in patients with mild to moderate psoriasis: results from a randomized double‐blind placebo‐controlled, phase II trial
Background  There is a need for the development of novel non‐steroidal topical drugs for the treatment of psoriasis. 
2010
2010
Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial.
explain unique variance associated with sunbathing intentions and intentions to sun protect. For both analyses, age, sex, skin… Expand
  • figure 1
  • figure 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE